imipenem, anhydrous has been researched along with Central Nervous System Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bösmüller, C; Königsrainer, A; Margreiter, R; Steurer, W; Willeit, J | 1 |
| Abel, SR; Guba, EA | 1 |
| Calandra, G; Carrigan, J; Guess, H; Lydick, E; Weiss, L | 1 |
| Brown, AL; Jacobs, RF; Kearns, GL; Longee, DC | 1 |
| Heimberger, K; Schein, W; Shaheen, FA; Stockenhuber, F; Zazgornik, J | 1 |
1 trial(s) available for imipenem, anhydrous and Central Nervous System Disease
| Article | Year |
|---|---|
Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.
Topics: Anti-Bacterial Agents; Bacterial Infections; Body Weight; Central Nervous System Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Kidney Function Tests; Male; Regression Analysis; Retrospective Studies; Risk Factors; Seizures; Thienamycins; Time Factors; United States | 1988 |
4 other study(ies) available for imipenem, anhydrous and Central Nervous System Disease
| Article | Year |
|---|---|
Increased risk of central nervous system toxicity in patients treated with ciclosporin and imipenem/cilastatin.
Topics: Adult; Central Nervous System; Central Nervous System Diseases; Cilastatin; Cyclosporins; Female; Humans; Imipenem; Male; Middle Aged; Risk Factors | 1991 |
Evaluation of an imipenem/cilastatin target drug program.
Topics: Adult; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Central Nervous System Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Cost Savings; Drug Combinations; Drug Costs; Drug Monitoring; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Kidney Diseases; Pharmacy Service, Hospital | 1991 |
Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections.
Topics: Central Nervous System Diseases; Child; Child, Preschool; Cilastatin; Cyclopropanes; Humans; Imipenem; Infant; Meningitis; Microbial Sensitivity Tests; Thienamycins | 1986 |
Potentiation of neurotoxic side effects by coadministration of imipenem to cyclosporine therapy in a kidney transplant recipient--synergism of side effects or drug interaction?
Topics: Central Nervous System Diseases; Cilastatin; Cyclopropanes; Cyclosporins; Drug Interactions; Drug Synergism; Female; Humans; Imipenem; Middle Aged; Thienamycins | 1986 |